Reversible hypertrophic cardiomyopathy in congenital hyperinsulinism

Acta Cardiologica

Volumn 54, Issue 6, 1999, Pages 359-361

  Massin, Martial M ^a   Van Elmbt, Gwenaelle ^b   Soyeur, Daniel ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NONE

Author keywords

Hyperinsulinism; Hypertrophic cardiomyopathy; Infant

Indexed keywords

ARTICLE; CASE REPORT; DISEASE COURSE; HUMAN; HYPERINSULINISM; HYPERTROPHIC CARDIOMYOPATHY; MALE; NEWBORN; PANCREAS RESECTION;

CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; HYPERINSULINISM; INFANT, NEWBORN; MALE; PANCREATECTOMY;

EID: 0033372804     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gutgesell HP, Speer ME, Rosenberg HS. Characterization of the cardiomyopathy in infants of diabetic mothers. Circulation 1980; 61: 441-450.
2. Reller MD, Tsang RC, Meyer RA, Braun CP. Relationship of prospective diabetes control in pregnancy to neonatal cardiorespiratory function. J Pediatr 1985; 106: 86-90.
3. Breitweser JA, Meyer RA, Sperling MA, Tsang RC, Kaplan S. Cardiac septal hypertrophy in hyperinsulinemic infants. J Pediatr 1980; 96: 535-539.
4. Carter BS, DiGiacomo JE, Balderston SM, Wiggins JW, Merenstein GB. Disproportionate septal hypertrophy associated with erythroblastosis fetalis. Am J Dis Child 1990; 144: 1225-1228.
5. Nuchpuckdee P, Brodsky N, Porat R, Hurt N. Ventricular septal thickness and cardiac function in neonates after in utero ritodrine exposure. J Pediatr 1986; 109: 687-691.
6. Ryan CA, Boyle MH, Burggraf GW. Reversible obstructive hypertrophic cardiomyopathy in the Beckwith-Wiedemann syndrome. Pediatr Cardiol 1989; 10: 225-228.
7. Rheuban KS, Blizzard RM, Parker MA, Carter T, Wilson T, Gutgesell HP. Hypertrophic cardiomyopathy in total lipodystrophy. J Pediatr 1986; 109: 301-302.
8. Geffner ME, Kaplan SA, Bersch N, Lippe BM, Smith WG, Nagel RA, Santulli TV Jr, Li CH, Golde DW. Leprechaunism: in vitro insulin action despite genetic insulin resistance. Pediatr Res 1987; 22: 286-291.
9. Gill AW, Warner G, Bull L. Iatrogenic neonatal hypertrophic cardiomyopathy. Pediatr Cardiol 1996; 17: 335-339.
10. Harris JP, Ricker AT, Gray RS, Steed RD, Gutai JJP. Reversible hypertrophic cardiomyopathy associated with nesidioblastosis. J Pediatr 1992; 120: 272-275.
11. Hausdorf G, Gravinghoff L, Rettig T, Hellwege HH, Keck EW. Hypertrophic obstructive cardiomyopathy in neonatal beta-cell adenoma of the pancreas. Pediatr Cardiol 1988; 9: 179-181.
12. Thorsson AV, Hintz RL. Insulin receptors in the newborn. N Engl J Med 1977; 297: 908-912.
13. Toyozaki T, Hiroe M, Hasumi M, Horie T, Hosoda S, Tsushima T, Sekiguchi M. Insulin-like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy. Jpn Circ J 1993; 57: 1120-1127.
14. Vetter U, Kupferschmidt C, Lang D, Pentz S. Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro. Basic Res Cardiol 1988; 83: 647-654.
15. Engelmann GL, Haskell JF, Boehm KD. Insulin-like growth factors and heart development. In: LeRoith D, Raizada MK, eds. Molecular and cellular biology of insulin-like growth factors and their receptors. Plenum Press, New-York, 1989: 443-458.
16. Werner JC, Sicard RE, Hansen TWR, Solomon E, Cowett RM, Oh W. Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 1992; 120: 63-64.
17. Morris HG. Pharmacology of corticosteroids in asthma. In: Middleton E Jr, Reed CE, Ellis EF, eds. Allergy: principles and practice. CV Mosby, St-Louis, 1983: 593-611.
18. Parker JJ, Allen DB. Hypertrophic cardiomyopathy after prolonged diazoxide for hyperinsulinemic hypoglycemia. J Pediatr 1991; 118: 906-909.